Pivoting Oncology Launch Plans Amid COVID-19

The pandemic has affected how new therapies are commercially launched. This has led to many life science manufacturers having to pivot to ensure patients are able to access the medications they need. Unprecedented times have led to them seeking a fresh approach and turning to Vynamic for support in planning and executing oncology launches.

In this case study, Vynamic assists two pharmaceutical companies in forming an alliance to launch two separate oncology products. Working both externally and internally, Vynamic mapped out four key changes to ensure both launches were successful from day one.

Vynamic also demonstrates how a brand can grow its share within the market two months post-approval through a coordinated and targeted virtual customer engagement plan and digital execution.

Read the full case study here.